Company Search:
Advanced Search
Sponsored Links
H. Lundbeck A/S Company Snapshot
H. Lundbeck A/S operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares H. Lundbeck A/S with three other pharmaceutical manufacturers in Europe: Jazz Pharmaceuticals Plc of IRELAND (2019 sales of 1.93 billion Euros [US$2.27 billion] of which 76% was Xyrem), Stada Arzneimittel AG of GERMANY (2.61 billion Euros [US$3.06 billion] of which 59% was Generics), and Hikma Pharmaceuticals PLC which is based in UNITED KINGDOM (£1.72 billion [US$2.25 billion] of which 41% was Injectable Pharmaceuticals).

Sales Analysis. H. Lundbeck A/S reported sales of 17.04 billion Danish Kroner (US$2.69 billion) for the year ending December of 2019. This represents a decrease of 6.0% versus 2018, when the company's sales were 18.12 billion Danish Kroner.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
H. Lundbeck A/S
  Stock Performance Chart for H. Lundbeck A/S
  Stock Data: Recent Stock Performance:
  Current Price (8/7/2020): 234.60
(Figures in Danish Kroner)
1 Week 2.0%   13 Weeks -3.1%  
4 Weeks -3.3%   52 Weeks -11.6%  
H. Lundbeck A/S Key Data:
  Ticker: LUN Country: Denmark
  Exchanges: CPH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 17,036,000,000
(Year Ending Jan 2020).
Employees: 5,806
  Currency: Danish Kroner Market Cap: 46,615,420,228
  Fiscal Yr Ends: December Shares Outstanding: 198,701,706
  Share Type: Stammaktie Closely Held Shares: 137,351,918
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.